Ibogaine is understood to be classified as a Category 1 narcotic in Thailand under the Narcotics Act B.E. 2522 (1979), making its possession, use, import, and distribution subject to severe criminal penalties. Last verified: April 2026.

Important Notice: Thailand enforces some of the strictest drug laws in Southeast Asia. Penalties for narcotic offenses can include lengthy imprisonment and, in cases involving large quantities, the death penalty. This page is informational only and does not constitute legal advice. Consult a licensed Thai attorney before making any decisions.

Current Legal Status

Thailand's primary legislation governing controlled substances is the Narcotics Act B.E. 2522 (1979) and its subsequent amendments. This law establishes five categories of controlled narcotics, with Category 1 representing the most severely restricted substances — those deemed to have no accepted medical use and high potential for abuse.

Ibogaine (and its primary alkaloid source, the Tabernanthe iboga plant) is understood by practitioners and legal observers to fall within Category 1 of this framework. However, it is important to acknowledge a significant limitation: ibogaine's specific scheduling status is not prominently documented in English-language official sources, and the Thai Food and Drug Administration (Thai FDA) and Office of the Narcotics Control Board (ONCB) maintain their authoritative controlled substance lists primarily in Thai.

Readers are strongly encouraged to:

  • Consult the Thai FDA's official narcotics schedule, available through fda.moph.go.th (Thai language)
  • Contact the Office of the Narcotics Control Board (ONCB) directly at oncb.go.th
  • Seek written legal opinion from a licensed Thai attorney before drawing any conclusions

If ibogaine is confirmed as a Category 1 narcotic, the legal consequences under Thai law include:

  • Possession: Up to 10 years imprisonment and/or a fine of up to 1,000,000 Thai Baht
  • Production or import: Imprisonment of 1 to 10 years and significant fines; escalating to life imprisonment or death penalty for large quantities
  • Distribution or trafficking: Penalties can reach life imprisonment or the death penalty depending on quantity

There are no known religious exemptions, medical research carve-outs, or harm reduction exceptions that would permit ibogaine use in Thailand. Unlike some countries that have decriminalized personal use of certain substances, Thailand maintains strict criminal liability for all categories of narcotics offenses regardless of the quantity or intent.

Treatment Centers

There are no known legal ibogaine treatment clinics operating in Thailand. Given the understood Category 1 classification, operating a clinic administering ibogaine would expose operators and patients alike to serious criminal jeopardy under Thai law.

Thailand does have a well-developed medical tourism infrastructure for other treatments, and the country has shown interest in certain alternative therapies — most notably, Thailand legalized cannabis for medical and recreational use in recent years before subsequently reversing course on recreational use. However, ibogaine has not been part of any similar reform discussion at a policy level currently visible in public records.

For a full directory of ibogaine clinics operating in countries where treatment is legal or tolerated, see our clinic directory. Many patients from Thailand travel to Mexico, Portugal, or the Netherlands for treatment.

How People Access Ibogaine in Thailand

This section describes factual patterns that have been reported; it does not constitute a recommendation or endorsement of any activity that violates Thai law.

Given the understood legal prohibition, people in Thailand who seek ibogaine treatment typically do so by traveling abroad to jurisdictions where treatment is legal or tolerated. Common destinations for Thai nationals and expatriates residing in Thailand include:

  • Mexico — The largest concentration of ibogaine clinics globally, operating legally under Mexican law
  • Portugal — Ibogaine is decriminalized for personal use under Portugal's harm reduction framework
  • The Netherlands — Ibogaine occupies a legal gray area and clinics operate under medical supervision
  • South Africa — Ibogaine is unscheduled and treatment centers operate legally

Attempting to bring ibogaine into Thailand after treatment abroad would constitute importation of a controlled substance and carries grave legal risk. Travelers should be aware that Thai customs and border authorities are thorough, and international airports such as Suvarnabhumi are known for rigorous enforcement of narcotics laws.

Recent Legal Developments

Thailand has undergone significant drug policy shifts in recent years, though none have directly affected ibogaine's status:

  • Cannabis policy reversal (2024–2026): After decriminalizing cannabis in 2022, Thailand moved to re-restrict recreational cannabis use. This trajectory demonstrates the Thai government's capacity for rapid policy change in both directions and underscores the importance of verifying current ibogaine status against official sources rather than assuming stability.
  • Kratom legalization (2021): Thailand legalized kratom (Mitragyna speciosa), a plant with psychoactive properties, removing it from the narcotics list. While this demonstrated some openness to plant-based medicine reform, kratom legalization has not created a precedent or pathway for ibogaine reform.
  • No ibogaine-specific legislative activity: As of April 2026, there is no publicly documented legislative proposal, parliamentary discussion, or regulatory review addressing ibogaine specifically in Thailand.

The overall direction of Thai drug policy currently appears to favor cautious re-regulation rather than broad decriminalization. Observers should monitor ONCB announcements and the Royal Gazette for any future scheduling changes.

Risks of Seeking Treatment in Thailand

Beyond the severe legal risks described above, those considering ibogaine in any context in Thailand should be aware of additional concerns:

  • No regulated treatment environment: Because no legal clinic framework exists, anyone offering ibogaine in Thailand operates entirely outside regulatory oversight. There are no licensing requirements, no mandatory medical screening protocols, and no enforceable quality standards for any substance being administered.
  • No medical recourse: A patient who experiences an adverse cardiac event or other medical emergency after receiving ibogaine in Thailand would be in a legally precarious position, and the provider would face criminal liability. This creates a strong incentive for clandestine operators to avoid calling emergency services, significantly increasing the risk of preventable death.
  • Ibogaine's inherent medical risks: Even in fully legal, well-regulated settings, ibogaine carries significant risks including cardiac arrhythmia (particularly QT interval prolongation), seizures, and dangerous interactions with other substances including opioids, stimulants, and certain antidepressants. Appropriate ibogaine treatment requires pre-treatment cardiac screening (ECG), medical supervision, and resuscitation capability — conditions that are extremely unlikely to be met in an unregulated setting.
  • Law enforcement exposure: Foreign nationals arrested on narcotics charges in Thailand may face lengthy pre-trial detention, limited consular support depending on nationality, and sentences that significantly exceed those in their home countries.
  • Substance authenticity: Outside a regulated supply chain, there is no reliable way to verify that a substance sold as ibogaine is what it claims to be, at the claimed concentration, and free of adulterants.
For those seeking treatment for opioid use disorder or other conditions: Thailand has a network of government-supported addiction treatment centers operated under the Department of Mental Health and the ONCB. These services offer evidence-based treatments within a legal framework. Contact the ONCB or a licensed Thai physician for referrals.

Frequently Asked Questions

Ibogaine is understood to be classified as a Category 1 narcotic under Thailand's Narcotics Act B.E. 2522 (1979), which would make its possession, use, import, and distribution illegal with severe penalties. However, because ibogaine's specific scheduling is not prominently documented in English-language official sources, readers should verify its status directly against the Thai FDA's official narcotics schedule (available in Thai at fda.moph.go.th) or consult a licensed Thai attorney. The practical enforcement reality is that ibogaine would be treated as a serious controlled substance by Thai authorities regardless of any ambiguity in English-language documentation.
If ibogaine is confirmed as a Category 1 narcotic, possession can result in up to 10 years imprisonment and fines up to 1,000,000 Thai Baht. For production, import, or export, penalties range from 1 to 10 years and can escalate dramatically based on quantity — potentially reaching life imprisonment or the death penalty for large-scale trafficking. Thailand's drug enforcement system is not known for leniency, and foreign nationals are not exempt from these penalties. Pre-trial detention periods can also be lengthy. Always consult a licensed Thai attorney if you have specific legal concerns.
Receiving ibogaine treatment in a country where it is legal does not create any legal liability in Thailand, provided no ibogaine or related substances are brought into the country. Importing ibogaine into Thailand — including carrying it in personal baggage, shipping it by mail, or any other means — would constitute importation of a controlled narcotic and carries serious criminal penalties. Thai customs and airport security at major international hubs such as Suvarnabhumi Airport are known for rigorous enforcement. Travelers should not attempt to bring any quantity of ibogaine, iboga root bark, or related preparations into Thailand.
No. There are no known legal ibogaine treatment clinics operating in Thailand as of April 2026. Operating such a clinic would expose both providers and patients to serious criminal liability under Thai narcotics law. Thailand does not currently have any regulatory pathway that would permit medical or clinical use of ibogaine. Patients seeking ibogaine treatment typically travel to jurisdictions where it is legal or decriminalized, such as Mexico, Portugal, the Netherlands, or South Africa. See our clinic directory for a full list of operating treatment centers worldwide.
As of April 2026, there is no publicly documented legislative proposal, parliamentary discussion, or regulatory review specifically addressing ibogaine in Thailand. While Thailand has made notable drug policy changes in recent years — most prominently the legalization and subsequent re-restriction of cannabis, and the removal of kratom from the narcotics list in 2021 — these reforms have not extended to ibogaine. The overall direction of Thai drug policy currently favors cautious case-by-case reform rather than broad decriminalization. Those interested in this topic should monitor announcements from the ONCB and the Royal Gazette for any future changes.
The most authoritative sources for Thailand's narcotics schedules are: (1) the Thai Food and Drug Administration at fda.moph.go.th, which publishes official controlled substance lists primarily in Thai; (2) the Office of the Narcotics Control Board (ONCB) at oncb.go.th; and (3) the Royal Gazette, where official regulatory changes are published. Because these resources are primarily in Thai, non-Thai speakers are advised to work with a licensed Thai attorney or a qualified translator to obtain an accurate interpretation of current scheduling status. Do not rely solely on English-language secondary sources, including this page, for legal decisions.

Informational only. Not legal advice. Laws change. Verify with a licensed attorney before making any decisions.